A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT02803918 · COMPLETED
Trial details
- NCT number
- NCT02803918
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-17
- Primary completion
- 2020-01-27
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.